Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 145-152, May 2006

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy☆

  • Christof Kazda

      Affiliations

    • Lilly Deutschland GmbH, Bad Homburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 0 6172 273 961; fax: +49 0 6172 273 2182.
    • ,
  • Hiltrud Hülstrunk

      Affiliations

    • Lilly Deutschland GmbH, Bad Homburg, Germany
    • ,
  • Karin Helsberg

      Affiliations

    • Lilly Deutschland GmbH, Bad Homburg, Germany
    • ,
  • Frank Langer

      Affiliations

    • Lilly Deutschland GmbH, Bad Homburg, Germany
    • ,
  • Thomas Forst

      Affiliations

    • Institute for Clinical Research and Development, Mainz, Germany
    • ,
  • Markolf Hanefeld

      Affiliations

    • Center for Clinical Studies, GWT Technical University, Dresden, Germany

Received 18 April 2005; received in revised form 1 September 2005; accepted 19 September 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported by grants from Lilly Deutschland GmbH, Bad Homburg, Germany.

PII: S1056-8727(05)00124-8

doi:10.1016/j.jdiacomp.2005.09.004

Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 145-152, May 2006

Article Tools

* Image Usage & Resolution